Cytotoxic T lymphocyte antigen-4 (CTLA-4) expression in chordoma and tumor-infiltrating lymphocytes (TILs) predicts prognosis of spinal chordoma

被引:0
作者
G. He
X. Liu
X. Pan
Y. Ma
X. Liu
机构
[1] Peking University Third Hospital,Department of Orthopedics, North Garden Street
[2] Peking University Third Hospital,The Center for Pain Medicine, North Garden Street
来源
Clinical and Translational Oncology | 2020年 / 22卷
关键词
CTLA-4; Immunohistochemistry; Chordoma; TILs; Prognosis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:2324 / 2332
页数:8
相关论文
共 263 条
[1]  
Matsumoto T(2013)Total spondylectomy following carbon ion radiotherapy to treat chordoma of the mobile spine Bone Joint J 95 1392-5
[2]  
Imagama S(2006)Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor Int J Radiat Oncol Biol Phys 65 1514-1521
[3]  
Ito Z(2006)Patient outcome at long-term follow-up after aggressive microsurgical resection of cranial base chordomas Neurosurgery 59 230-7
[4]  
Imai R(2014)A review of the surgical management of sacral chordoma Eur J Surg Oncol 40 1412-1420
[5]  
Kamada T(2016)Immunotherapy as a potential treatment for chordoma: a review Curr Oncol Rep 18 55-1151
[6]  
Shimoyama Y(2015)Immunotherapy: Checkpoint parley Nat Rev Cancer 15 3-486
[7]  
Matsuyama Y(2017)CTLA-4 blockade in mesothelioma: ineffective or reason for optimism? Lancet Oncol 18 1150-11149
[8]  
Ishiguro N(2016)Safety profiles of anti-CTLA-4 and anti-PD-1 antibodies alone and in combination Nat Rev Clin Oncol 13 473-11149
[9]  
Park L(2017)First report of clinical responses to immunotherapy in 3 relapsing cases of chordoma after failure of standard therapies Oncoimmunology 6 e1338235-270
[10]  
Delaney TF(2015)Expression of programmed cell death ligand 1 (PD-L1) and prevalence of tumor-infiltrating lymphocytes (TILs) in chordoma Oncotarget 6 11139-396